-
1
-
-
33646577163
-
Genetics and biology of pancreatic ductal adenocarcinoma
-
DOI 10.1101/gad.1415606
-
AF Hezel AC Kimmelman B Stanger N Bardeesy RA DePinho 2006 Genetics and biology of pancreatic ductal adenocarcinoma Genes Develop 20 1218 1249 1:CAS:528:DC%2BD28XltVyrtb4%3D 10.1101/gad.1415606 16702400 (Pubitemid 43727584)
-
(2006)
Genes and Development
, vol.20
, Issue.10
, pp. 1218-1249
-
-
Hezel, A.F.1
Kimmelman, A.C.2
Stanger, B.Z.3
Bardeesy, N.4
DePinho, R.A.5
-
2
-
-
18844453135
-
Surgery for pancreatic cancer: Recent controversies and current practice
-
DOI 10.1053/j.gastro.2005.03.035, PII S0016508505004610
-
CJ Wray SA Ahmad JB Matthews AM Lowy 2005 Surgery for pancreatic cancer: recent controversies and current practice Gastroenterology 128 1626 1641 10.1053/j.gastro.2005.03.035 15887155 (Pubitemid 40692556)
-
(2005)
Gastroenterology
, vol.128
, Issue.6
, pp. 1626-1641
-
-
Wray, C.J.1
Ahmad, S.A.2
Matthews, J.B.3
Lowy, A.M.4
-
3
-
-
67650874081
-
Cancer statistics, 2009
-
10.3322/caac.20006 19474385
-
A Jemal R Siegel E Ward Y Hao J Xu MJ Thun 2009 Cancer statistics, 2009 CA Cancer J Clin 59 225 249 10.3322/caac.20006 19474385
-
(2009)
CA Cancer J Clin
, vol.59
, pp. 225-249
-
-
Jemal, A.1
Siegel, R.2
Ward, E.3
Hao, Y.4
Xu, J.5
Thun, M.J.6
-
4
-
-
0035093234
-
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration
-
1:STN:280:DC%2BD3Mzgt1agsw%3D%3D 10.1007/s10434-001-0123-4 11258776
-
TM Breslin, et al. 2001 Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival duration Ann Surg Oncol 8 123 132 1:STN:280:DC%2BD3Mzgt1agsw%3D%3D 10.1007/s10434-001-0123-4 11258776
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 123-132
-
-
Breslin, T.M.1
-
6
-
-
33746088024
-
Metastasis suppressor proteins: Discovery, molecular mechanisms, and clinical application
-
DOI 10.1158/1078-0432.CCR-06-1014
-
CW Rinker-Schaeffer JP O'Keefe DR Welch D Theodorescu 2006 Metastasis suppressor proteins: discovery, molecular mechanisms, and clinical application Clin Cancer Res 12 3882 3889 1:CAS:528:DC%2BD28XmsValtrc%3D 10.1158/1078-0432. CCR-06-1014 16818682 (Pubitemid 44078070)
-
(2006)
Clinical Cancer Research
, vol.12
, Issue.13
, pp. 3882-3889
-
-
Rinker-Schaeffer, C.W.1
O'Keefe, J.P.2
Welch, D.R.3
Theodorescu, D.4
-
7
-
-
33646541350
-
Novel functions of TIMPs in cell signaling
-
DOI 10.1007/s10555-006-7893-x, Metalloproteinases and Cancer
-
R Chirco XW Liu KK Jung HR Kim 2006 Novel functions of TIMPs in cell signaling Cancer Metastasis Rev 25 99 113 1:CAS:528:DC%2BD28Xktlaksro%3D 10.1007/s10555-006-7893-x 16680576 (Pubitemid 43723986)
-
(2006)
Cancer and Metastasis Reviews
, vol.25
, Issue.1
, pp. 99-113
-
-
Chirco, R.1
Liu, X.-W.2
Jung, K.-K.3
Kim, H.-R.C.4
-
8
-
-
0031600391
-
Nm23 and tumour metastasis: Basic and translational advances
-
1:CAS:528:DyaK1cXptlGh
-
JM Freije NJ MacDonald PS Steeg 1998 Nm23 and tumour metastasis: basic and translational advances Biochem Soc Symposia 63 261 271 1:CAS:528: DyaK1cXptlGh
-
(1998)
Biochem Soc Symposia
, vol.63
, pp. 261-271
-
-
Freije, J.M.1
MacDonald, N.J.2
Steeg, P.S.3
-
9
-
-
40149091965
-
Metastasis suppressors genes in cancer
-
1:CAS:528:DC%2BD1cXjtVekur8%3D 10.1016/j.biocel.2007.12.016 18280770
-
LJ Stafford KS Vaidya DR Welch 2008 Metastasis suppressors genes in cancer Int J Biochem Cell Biol 40 874 891 1:CAS:528:DC%2BD1cXjtVekur8%3D 10.1016/j.biocel.2007.12.016 18280770
-
(2008)
Int J Biochem Cell Biol
, vol.40
, pp. 874-891
-
-
Stafford, L.J.1
Vaidya, K.S.2
Welch, D.R.3
-
10
-
-
0037264812
-
Metastasis suppressors alter the signal transduction of cancer cells
-
DOI 10.1038/nrc967
-
PS Steeg 2003 Metastasis suppressors alter the signal transduction of cancer cells Nat Rev Cancer 3 55 63 1:CAS:528:DC%2BD38XpvVertbw%3D 10.1038/nrc967 12509767 (Pubitemid 37328887)
-
(2003)
Nature Reviews Cancer
, vol.3
, Issue.1
, pp. 55-63
-
-
Steeg, P.S.1
-
11
-
-
27744480252
-
KiSS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha
-
DOI 10.1007/s10585-005-8186-4
-
Y Jiang M Berk LS Singh HY Tan LH Yin CT Powell, et al. 2005 KISS1 suppresses metastasis in human ovarian cancer via inhibition of protein kinase C alpha Clin Exp Metastasis 22 369 376 1:CAS:528:DC%2BD28Xit1KlsQ%3D%3D 10.1007/s10585-005-8186-4 16283480 (Pubitemid 41609296)
-
(2005)
Clinical and Experimental Metastasis
, vol.22
, Issue.5
, pp. 369-376
-
-
Jiang, Y.1
Berk, M.2
Singh, L.S.3
Tan, H.4
Yin, L.5
Powell, C.T.6
Xu, Y.7
-
12
-
-
0036791113
-
Identification and characterization of mouse metastasis-suppressor KISS1 and its G-protein-coupled receptor
-
1:CAS:528:DC%2BD38Xnsl2lsrk%3D 12359743
-
LJ Stafford CZ Xia WB Ma Y Cai MY Liu 2002 Identification and characterization of mouse metastasis-suppressor KISS1 and its G-protein-coupled receptor Cancer Res 62 5399 5404 1:CAS:528:DC%2BD38Xnsl2lsrk%3D 12359743
-
(2002)
Cancer Res
, vol.62
, pp. 5399-5404
-
-
Stafford, L.J.1
Xia, C.Z.2
Ma, W.B.3
Cai, Y.4
Liu, M.Y.5
-
13
-
-
10744221941
-
Metastin and its variant forms suppress migration of pancreatic cancer cells
-
DOI 10.1016/j.bbrc.2004.01.021
-
T Masui R Doi T Mori, et al. 2004 Metastin and its variant forms suppress migration of pancreatic cancer cells Biochem Biophys Res Commun 315 85 92 1:CAS:528:DC%2BD2cXps1KqsQ%3D%3D 10.1016/j.bbrc.2004.01.021 15013429 (Pubitemid 38175189)
-
(2004)
Biochemical and Biophysical Research Communications
, vol.315
, Issue.1
, pp. 85-92
-
-
Masui, T.1
Doi, R.2
Mori, T.3
Toyoda, E.4
Koizumi, M.5
Kami, K.6
Ito, D.7
Peiper, S.C.8
Broach, J.R.9
Oishi, S.10
Niida, A.11
Fujii, N.12
Imamura, M.13
-
14
-
-
60149108488
-
Prognostic value of metastin expression in human pancreatic cancer
-
K Nagai R Doi F Katagiri T Ito A Kida M Koizumi T Masui Y Kawaguchi K Tomita S Oishi N Fujii S Uemoto 2009 Prognostic value of metastin expression in human pancreatic cancer J Exp Clin Cancer Res 21 28 29
-
(2009)
J Exp Clin Cancer Res
, vol.21
, pp. 28-29
-
-
Nagai, K.1
Doi, R.2
Katagiri, F.3
Ito, T.4
Kida, A.5
Koizumi, M.6
Masui, T.7
Kawaguchi, Y.8
Tomita, K.9
Oishi, S.10
Fujii, N.11
Uemoto, S.12
-
15
-
-
64849103118
-
Clinical significance of plasma metastin level in pancreatic cancer patients
-
1:CAS:528:DC%2BD1MXjvVWhtLk%3D 19212644
-
F Katagiri K Nagai A Kida K Tomita S Oishi M Takeyama R Doi N Fujii 2009 Clinical significance of plasma metastin level in pancreatic cancer patients Oncol Rep 21 815 819 1:CAS:528:DC%2BD1MXjvVWhtLk%3D 19212644
-
(2009)
Oncol Rep
, vol.21
, pp. 815-819
-
-
Katagiri, F.1
Nagai, K.2
Kida, A.3
Tomita, K.4
Oishi, S.5
Takeyama, M.6
Doi, R.7
Fujii, N.8
-
16
-
-
0033542130
-
High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential
-
DOI 10.1006/bbrc.1999.0653
-
N Akisawa I Nishimori T Iwamura S Onishi MA Hollingsworth 1999 High levels of ezrin expressed by human pancreatic adenocarcinoma cell lines with high metastatic potential Biochem Biophys Res Commun 258 395 400 1:CAS:528:DyaK1MXjtVertb0%3D 10.1006/bbrc.1999.0653 10329398 (Pubitemid 29287062)
-
(1999)
Biochemical and Biophysical Research Communications
, vol.258
, Issue.2
, pp. 395-400
-
-
Akisawa, N.1
Nishimori, I.2
Iwamura, T.3
Onishi, S.4
Hollingsworth, M.A.5
-
17
-
-
0037100983
-
A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer
-
10.1038/sj.bjc.6600446
-
N Kitamura T Iwamura S Taniguchi H Yamanari K Kawano SR Holli J Bramhall J Schulz PD Nemunaitis BailletM Brown JA Buckels 2002 A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer Br J Cancer 87 161 167 10.1038/sj.bjc.6600446
-
(2002)
Br J Cancer
, vol.87
, pp. 161-167
-
-
Kitamura, N.1
Iwamura, T.2
Taniguchi, S.3
Yamanari, H.4
Kawano, K.5
Holli, S.R.6
Bramhall, J.7
Schulz, J.8
Nemunaitis, P.D.9
Bailletm, B.10
Buckels, J.A.11
-
18
-
-
0034788499
-
High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice
-
MA Hollingsworth T Setoguchi 2001 High collagenolytic activity in spontaneously highly metastatic variants derived from a human pancreatic cancer cell line (SUIT-2) in nude mice Clin Exp Met 18 561 571
-
(2001)
Clin Exp Met
, vol.18
, pp. 561-571
-
-
Hollingsworth, M.A.1
Setoguchi, T.2
-
19
-
-
33847784034
-
Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy
-
DOI 10.1093/jnci/djk053
-
KT Nash PA Phadke JM Navenot DR Hurst MA Accavitti-Loper E Sztul KS Vaidya AR Frost JC Kappes SC Peiper DR Welch 2007 Requirement of KISS1 secretion for multiple organ metastasis suppression and maintenance of tumor dormancy J Natl Cancer Inst 99 309 321 1:CAS:528:DC%2BD2sXjsVeitrY%3D 10.1093/jnci/djk053 17312308 (Pubitemid 47078727)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.4
, pp. 309-321
-
-
Nash, K.T.1
Phadke, P.A.2
Navenot, J.-M.3
Hurst, D.R.4
Accavitti-Loper, M.A.5
Sztul, E.6
Vaidya, K.S.7
Frost, A.R.8
Kappes, J.C.9
Peiper, S.C.10
Welch, D.R.11
-
20
-
-
0034651781
-
Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction
-
DOI 10.1006/abio.1999.4461
-
MR Johnson K Wang JB Smith MJ Heslin RB Diasio 2000 Quantitation of dihydropyrimidine dehydrogenase expression by real-time reverse transcription polymerase chain reaction Anal Biochem 278 175 184 1:CAS:528: DC%2BD3cXoslKjtQ%3D%3D 10.1006/abio.1999.4461 10660460 (Pubitemid 30090740)
-
(2000)
Analytical Biochemistry
, vol.278
, Issue.2
, pp. 175-184
-
-
Johnson, M.R.1
Wang, K.2
Smith, J.B.3
Heslin, M.J.4
Diasio, R.B.5
-
21
-
-
34848912648
-
Combination treatment with TRA-8 anti-death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer
-
DOI 10.1158/1078-0432.CCR-07-1075
-
LC DeRosier DJ Buchsbaum PG Oliver ZQ Huang JC Sellers WE Grizzle W Wang T Zhou KR Zinn JW Long SM Vickers 2007 Combination treatment with TRA-8 anti death receptor 5 antibody and CPT-11 induces tumor regression in an orthotopic model of pancreatic cancer Clin Cancer Res 13 5535s 5543s 1:CAS:528: DC%2BD2sXhtVCitLrM 10.1158/1078-0432.CCR-07-1075 17875786 (Pubitemid 47510384)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.18
-
-
DeRosier, L.C.1
Buchsbaum, D.J.2
Oliver, P.G.3
Huang, Z.-Q.4
Sellers, J.C.5
Grizzle, W.E.6
Wang, W.7
Zhou, T.8
Zinn, K.R.9
Long, J.W.10
Vickers, S.M.11
-
22
-
-
54349110130
-
Pancreatic cancer: From molecular signature to target therapy
-
1:STN:280:DC%2BD1cjitl2itg%3D%3D 10.1016/j.critrevonc.2008.03.003 18436450
-
R Longo F Cacciamani G Naso G Gasparini 2008 Pancreatic cancer: from molecular signature to target therapy Crit Rev Oncol Hematol 68 197 211 1:STN:280:DC%2BD1cjitl2itg%3D%3D 10.1016/j.critrevonc.2008.03.003 18436450
-
(2008)
Crit Rev Oncol Hematol
, vol.68
, pp. 197-211
-
-
Longo, R.1
Cacciamani, F.2
Naso, G.3
Gasparini, G.4
-
23
-
-
4143123501
-
Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma
-
DOI 10.1002/ijc.20357
-
DK Dhar H Naora H Kubota R Maruyama H Yoshimura Y Tonomoto, et al. 2004 Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma Int J Cancer 111 868 872 1:CAS:528: DC%2BD2cXntVantrc%3D 10.1002/ijc.20357 15300798 (Pubitemid 39096235)
-
(2004)
International Journal of Cancer
, vol.111
, Issue.6
, pp. 868-872
-
-
Dhar, D.K.1
Naora, H.2
Kubota, H.3
Maruyama, R.4
Yoshimura, H.5
Tonomoto, Y.6
Tachibana, M.7
Ono, T.8
Otani, H.9
Nagasue, N.10
-
24
-
-
34547814250
-
The missing kiss of life: Transcriptional activity of the metastasis suppressor gene KISS1 in early breast cancer
-
1:CAS:528:DC%2BD2sXpvFChs7Y%3D 17695545
-
L Kostadima G Pentheroudakis N Pavlidis 2007 The missing kiss of life: transcriptional activity of the metastasis suppressor gene KISS1 in early breast cancer Anticancer Res 27 2499 2504 1:CAS:528:DC%2BD2sXpvFChs7Y%3D 17695545
-
(2007)
Anticancer Res
, vol.27
, pp. 2499-2504
-
-
Kostadima, L.1
Pentheroudakis, G.2
Pavlidis, N.3
-
25
-
-
38349053162
-
Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma
-
Prentice, LM, Klausen, C, Kalloger, S, Köbel M, McKinney S, Santos JL, et al (2007) Kisspeptin and GPR54 immunoreactivity in a cohort of 518 patients defines favourable prognosis and clear cell subtype in ovarian carcinoma. BMC Med 5:33
-
(2007)
BMC Med
, vol.5
, pp. 33
-
-
Prentice, L.1
-
26
-
-
0029808561
-
KiSS-1, a novel human malignant melanoma metastasis-suppressor gene
-
1:STN:280:DyaK2s%2FpvFChtA%3D%3D 10.1093/jnci/88.23.1731 8944003
-
JH Lee ME Miele DJ Hicks KK Phillips JM Trent BE Weissman DR Welch 1996 KiSS-1, a novel human malignant melanoma metastasis-suppressor gene J Natl Cancer Inst 88 1731 1737 1:STN:280:DyaK2s%2FpvFChtA%3D%3D 10.1093/jnci/88.23. 1731 8944003
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1731-1737
-
-
Lee, J.H.1
Miele, M.E.2
Hicks, D.J.3
Phillips, K.K.4
Trent, J.M.5
Weissman, B.E.6
Welch, D.R.7
-
27
-
-
0030956852
-
Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1
-
1:CAS:528:DyaK2sXjvFKitLw%3D 9192814
-
JH Lee DR Welch 1997 Suppression of metastasis in human breast carcinoma MDA-MB-435 cells after transfection with the metastasis suppressor gene, KiSS-1 Cancer Res 57 2384 2387 1:CAS:528:DyaK2sXjvFKitLw%3D 9192814
-
(1997)
Cancer Res
, vol.57
, pp. 2384-2387
-
-
Lee, J.H.1
Welch, D.R.2
|